Precision System Science Co. Ltd.
Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products. The company manufactures and sells plastic consumables, which are used in automated systems/instruments; reagents; and automated nucleic acid extraction systems. It also offers geneLEAD, an instrument … Read more
Precision System Science Co. Ltd. (PCNEF) - Net Assets
Latest net assets as of June 2025: $3.76 Billion USD
Based on the latest financial reports, Precision System Science Co. Ltd. (PCNEF) has net assets worth $3.76 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.94 Billion) and total liabilities ($1.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.76 Billion |
| % of Total Assets | 76.14% |
| Annual Growth Rate | 2.62% |
| 5-Year Change | -42.86% |
| 10-Year Change | 9.53% |
| Growth Volatility | 55.59 |
Precision System Science Co. Ltd. - Net Assets Trend (2008–2025)
This chart illustrates how Precision System Science Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Precision System Science Co. Ltd. (2008–2025)
The table below shows the annual net assets of Precision System Science Co. Ltd. from 2008 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $3.76 Billion | -9.27% |
| 2024-06-30 | $4.14 Billion | -20.67% |
| 2023-06-30 | $5.22 Billion | -19.81% |
| 2022-06-30 | $6.51 Billion | -1.01% |
| 2021-06-30 | $6.58 Billion | +52.26% |
| 2020-06-30 | $4.32 Billion | +8.64% |
| 2019-06-30 | $3.98 Billion | +20.84% |
| 2018-06-30 | $3.29 Billion | -12.26% |
| 2017-06-30 | $3.75 Billion | +9.30% |
| 2016-06-30 | $3.43 Billion | -14.94% |
| 2015-06-30 | $4.04 Billion | -6.70% |
| 2014-06-30 | $4.33 Billion | -47.52% |
| 2013-06-30 | $8.24 Billion | +215.29% |
| 2012-06-30 | $2.61 Billion | -8.67% |
| 2011-06-30 | $2.86 Billion | -15.09% |
| 2010-06-30 | $3.37 Billion | +31.70% |
| 2009-06-30 | $2.56 Billion | +5.59% |
| 2008-06-30 | $2.42 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Precision System Science Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24381000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $100.00 Million | 2.66% |
| Other Comprehensive Income | $52.00 Million | 1.38% |
| Other Components | $5.57 Billion | 148.28% |
| Total Equity | $3.76 Billion | 100.00% |
Precision System Science Co. Ltd. Competitors by Market Cap
The table below lists competitors of Precision System Science Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Twinhead International Corp
TW:2364
|
$44.59 Million |
|
Kunyue Development Co Ltd
TWO:5206
|
$44.60 Million |
|
Ok Biotech Co Ltd
TW:4155
|
$44.61 Million |
|
Hai Phong Hoang Ha Paper JSC
VN:HHP
|
$44.62 Million |
|
Southeastern Banking Corp
PINK:SEBC
|
$44.57 Million |
|
Commencement Bancorp Inc
OTCQX:CBWA
|
$44.57 Million |
|
Megasoft Limited
NSE:MEGASOFT
|
$44.57 Million |
|
Shih Kuen Plastics Co Ltd
TWO:4305
|
$44.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Precision System Science Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,142,850,000 to 3,759,000,000, a change of -383,850,000 (-9.3%).
- Net loss of 253,000,000 reduced equity.
- Share repurchases of 100,000,000 reduced equity.
- Other comprehensive income decreased equity by 30,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-253.00 Million | -6.73% |
| Share Repurchases | $100.00 Million | -2.66% |
| Other Comprehensive Income | $-30.00 Million | -0.8% |
| Other Changes | $-850.00K | -0.02% |
| Total Change | $- | -9.27% |
Book Value vs Market Value Analysis
This analysis compares Precision System Science Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-06-30 | $141.43 | $2.28 | x |
| 2009-06-30 | $280.16 | $2.28 | x |
| 2010-06-30 | $366.86 | $2.28 | x |
| 2011-06-30 | $148.37 | $2.28 | x |
| 2012-06-30 | $134.74 | $2.28 | x |
| 2013-06-30 | $269.77 | $2.28 | x |
| 2014-06-30 | $220.22 | $2.28 | x |
| 2015-06-30 | $202.47 | $2.28 | x |
| 2016-06-30 | $167.82 | $2.28 | x |
| 2017-06-30 | $179.03 | $2.28 | x |
| 2018-06-30 | $142.69 | $2.28 | x |
| 2019-06-30 | $162.18 | $2.28 | x |
| 2020-06-30 | $166.71 | $2.28 | x |
| 2021-06-30 | $240.53 | $2.28 | x |
| 2022-06-30 | $235.66 | $2.28 | x |
| 2023-06-30 | $188.99 | $2.28 | x |
| 2024-06-30 | $149.93 | $2.28 | x |
| 2025-06-30 | $136.73 | $2.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Precision System Science Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.39%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 1.31x
- Recent ROE (-6.73%) is below the historical average (-6.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -16.53% | -11.79% | 0.80x | 1.74x | $-642.92 Million |
| 2009 | 3.07% | 1.94% | 0.92x | 1.72x | $-166.44 Million |
| 2010 | 17.27% | 9.76% | 1.08x | 1.65x | $231.61 Million |
| 2011 | -13.54% | -11.67% | 0.68x | 1.70x | $-637.48 Million |
| 2012 | -7.69% | -5.37% | 0.77x | 1.86x | $-434.98 Million |
| 2013 | 20.60% | 25.17% | 0.35x | 2.33x | $522.01 Million |
| 2014 | 15.22% | 15.60% | 0.54x | 1.82x | $210.01 Million |
| 2015 | -5.82% | -4.18% | 0.80x | 1.75x | $-584.77 Million |
| 2016 | -46.65% | -35.48% | 0.77x | 1.72x | $-1.92 Billion |
| 2017 | -14.80% | -14.43% | 0.66x | 1.55x | $-930.35 Million |
| 2018 | -13.90% | -12.57% | 0.71x | 1.56x | $-786.76 Million |
| 2019 | 3.28% | 2.97% | 0.80x | 1.38x | $-267.40 Million |
| 2020 | -2.64% | -2.26% | 0.79x | 1.49x | $-546.35 Million |
| 2021 | 12.10% | 8.56% | 0.80x | 1.76x | $138.13 Million |
| 2022 | 0.70% | 0.61% | 0.65x | 1.75x | $-605.88 Million |
| 2023 | -25.36% | -25.09% | 0.54x | 1.87x | $-1.85 Billion |
| 2024 | -27.07% | -28.18% | 0.62x | 1.54x | $-1.54 Billion |
| 2025 | -6.73% | -5.39% | 0.95x | 1.31x | $-628.90 Million |
Industry Comparison
This section compares Precision System Science Co. Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Precision System Science Co. Ltd. (PCNEF) | $3.76 Billion | -16.53% | 0.31x | $44.57 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |